from todays announcement on presentations:
ChemGenex will also present combination data for Omapro during the poster session entitled: Chronic
Myeloid Leukemia - Therapy on Sunday, December 6th from 6:00 to 8:00 p.m. Central Time on Poster
Board II-170. This phase 2 trial was designed to study the “Combination of Omacetaxine and Imatinib
in the Treatment of Patients with CML in Advanced Stages or After Failure to Imatinib”.
Add to My Watchlist
What is My Watchlist?